Establishment and operation of a Good Manufacturing Practice-compliant allogeneic Epstein-Barr virus (EBV)-specific cytotoxic cell bank for the treatment of EBV-associated lymphoproliferative disease
Citation
Vickers , M A , Wilkie , G M , Robinson , N , Rivera , N , Haque , T , Crawford , D H , Barry , J , Fraser , N , Turner , D M , Robertson , V , Dyer , P , Flanagan , P , Newlands , H R , Campbell , J & Turner , M 2014 , ' Establishment and operation of a Good Manufacturing Practice-compliant allogeneic Epstein-Barr virus (EBV)-specific cytotoxic cell bank for the treatment of EBV-associated lymphoproliferative disease ' , British Journal of Haematology , vol. 167 , no. 3 , pp. 402-410 . https://doi.org/10.1111/bjh.13051